That whole process has still taken decades.
We may never completely control these Monsters, but we can catch them and preven them from taking off to produce an out of control epidemic.
This is an example of proper vaccine research. Proper application includes a halo of vaccination around those exposed to a victim. That can stop it cold. .
Ebola. The very word evokes fear, and with good reason. To date, the virus has been fatal for the majority of those who have contracted it.
Still, outbreaks are difficult to control, particularly when they occur in countries that lack infrastructure. Systems that aren’t equipped to deal with routine health needs, like preventative care, birth, and vaccinations, struggle even more during emergencies, especially ones that leave very contagious people dead on the streets. Distrust in government and in medical workers compounds the deadliness of the virus. Public health experts warn that emergency response is a more like a Band-Aid than a vaccine, and that investing in local health systems is the only way to ensure that Ebola—or another virus—doesn’t become a pandemic. Will we listen?
4: Known strains of the Ebola virus that humans can contract
21: Maximum days of incubation for the virus
19: Countries where Ebola has been detected
25 months: Duration of the largest Ebola epidemic, which occurred in West Africa between 2014-2016
11,310: Registered deaths in the 2014-2016 epidemic
2,142: Deaths in the ongoing epidemic in the Democratic Republic of the Congo (DRC) as of Oct. 5, 2019
8%: Share of Liberia’s doctors, nurses, and midwives who died during the 2014-2016 epidemic
$3.6 billion: International aid contributed by the US, Germany, and the UK for Ebola response in the 2014-2016 epidemic
40%: Mortality rate during the 2014-2016 epidemic in West Africa
67%: Mortality rate in the current epidemic in the DRC
In which of these bodily fluids can Ebola be found long after a patient has recovered?
1994: Health workers are broadly equipped with protective gear like gloves and masks for the first time.
1994-1995: The strain of virus responsible for the epidemic in DRC is isolated; it will be used to create the first Ebola vaccine.
1995: Antibodies found in a survivor are isolated and used to create one of two experimental retroviral treatments currently being tested.
2002: The development of the Ebola vaccine begins in the US.
2014: The first clinical trial for the vaccine is scheduled in West Africa.
2014-2016: West Africa experiences the largest Ebola epidemic to date with 28,000 people infected and 11,000 dead.
2018: The DRC announces the second Ebola outbreak of the year, which will go on to become the worst in the DRC’s history, and is still ongoing.
Volunteers can access a treatment that is still being developed with the idea that the danger they face with no treatment is so great that the risks of an ineffective treatment pale in comparison.